Get started
Author

Alexandru Garaiman

Observed names: A Garaiman, A. Garaiman, Garaiman A., Garaiman, Alexandru
ORCID: 0000-0003-2567-4039
Observed ORCID: 0000-0003-2567-4039
OpenAlex ID: A5089645830
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
2020 · Carina Mihai, Rucsandra Dobrota, et al. · Annals of the Rheumatic Diseases · 116
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
2021 · Mike O Becker, Rucsandra Dobrota, et al. · Annals of the Rheumatic Diseases · 36
PDF
Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
2022 · Alexandru Garaiman, Farhad Nooralahzadeh, et al. · Lara D. Veeken · 34
PDF
Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids
2012 · Irina Baran, Constanta Ganea, et al. · Oxidative Medicine and Cellular Longevity · 29
PDF
The Hospital Anxiety and Depression Scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort
2021 · Alexandru Garaiman, Carina Mihai, et al. · Clinical and Experimental Rheumatology · 28
PDF
Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and menadione in human leukemia Jurkat T cells
2015 · Ioana Teodora Tofolean, Constanta Ganea, et al. · Pharmacological Research · 25
Mitochondrial respiratory complex I probed by delayed luminescence spectroscopy
2013 · Irina Baran, Diana N. Ionescue, et al. · Journal of Biomedical Optics · 24
PDF
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
2022 · Alexandru Garaiman, Klaus Steigmiller, et al. · Lara D. Veeken · 21
PDF
The enigma of mixed connective tissue disease—challenges in routine care
2022 · Adrian Wanzenried, Alexandru Garaiman, et al. · Clinical Rheumatology · 20
PDF
Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis
2021 · Norina Zampatti, Alexandru Garaiman, et al. · Arthritis Research & Therapy · 16
PDF
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database
2025 · Qingran Yan, Cosimo Bruni, et al. · Annals of the Rheumatic Diseases · 14
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review
2024 · A Dima, MC Vonk, et al. · European Journal of Internal Medicine · 14
PDF
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
2024 · Moritz Scheidegger, Marouane Boubaya, et al. · RMD Open · 11
PDF
A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score
2025 · Cosimo Bruni, Lorenzo Tofani, et al. · Lara D. Veeken · 9
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
2024 · Lea Stamm, Alexandru Garaiman, et al. · RMD Open · 8
PDF
The incremental value of the contribution of a biostatistician to the reporting quality in health research—A retrospective, single center, observational cohort study
2022 · Ulrike Held, Klaus Steigmiller, et al. · PLoS ONE · 8
PDF
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis
2024 · Rucsandra Dobrota, Alexandru Garaiman, et al. · RMD Open · 5
PDF
Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis
2024 · Sinziana Muraru, Carina Mihai, et al. · Lara D. Veeken · 5
Pos0388 Developing a Screening Tool for the Detection of Interstitial Lung Disease in Systemic Sclerosis: the Ild-risc Risk Score
2022 · C. Bruni, L. Tofani, et al. · Annals of the Rheumatic Diseases · 5
PDF
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review
2024 · Dima A., Vonk M. C., et al. · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele · 3
Op0003 Does Immunosuppressive Therapy Improve Gastrointestinal Symptoms in Patients With Systemic Sclerosis?
2022 · L. Stamm, A. Garaiman, et al. · Annals of the Rheumatic Diseases · 3
PDF
Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography
2024 · Cosimo Bruni, Lorenzo Tofani, et al. · The Journal of Rheumatology · 2
PDF
Pos1273 Characteristics and Disease Course of Untreated Patients With Interstitial Lung Disease Associated With Systemic Sclerosis in a Real-life Two-center Cohort
2023 · M. Scheidegger, A. Garaiman, et al. · Annals of the Rheumatic Diseases · 2
PDF
Pos0877 the Effect of Platelet Inhibitors on Digital Ulcers in Systemic Sclerosis - a Derivation and Validation Eustar Study
2021 · A. Garaiman, K. Steigmiller, et al. · Annals of the Rheumatic Diseases · 2
Fri0267 Clinical Correlates and Relevance of Ucla Git 2.0 for Esophagitis and Indication for Esophagogastroduodenoscopy in Real-life Patients With Systemic Sclerosis
2020 · N. Zampatti, A. Garaiman, et al. · Annals of the Rheumatic Diseases · 2
PDF
Works count: 50
Citation count: 442
H-index: 12
I10-index: 13
Year
Topic
Type